Related Articles

Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey.

Eur Heart J. 2019 May 23;:

Authors: Packer M

PMID: 31121027 [PubMed – as supplied by publisher]

Source link